ZEB1 induces N‑cadherin expression in human glioblastoma and may alter patient survival
- 8 June 2022
- journal article
- research article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 17 (2) , 1-6
Abstract
The present study investigated the expression of epithelial‑mesenchymal transition (EMT)‑related factors zinc finger E‑box‑binding homeobox 1 (ZEB1), cadherin‑1 (CDH1), cadherin‑2 (CDH2) and the cell cycle modulating kinase cyclin‑dependent kinase 1 (CDK1) in human glioblastoma (GBM) compared to normal brain tissue, as well as whether the levels of expression were associated with the overall and progression‑free survival of the GBM patients. In 44 GBM and five normal brain tissue specimens, the expression levels of ZEB1, CDH1, CDH2 and CDK1 were evaluated by real‑time PCR and immunostaining, and the results were correlated with clinical data. The expression levels of all investigated genes as detected by immunostaining were significantly higher in the GBM when compared to the normal brain tissues. There was no influence on survival. A linear correlation between ZEB1 and CDH2 and CDK1 expression was observed in GBM. Moreover, ZEB1 was involved in EMT (e.g., signaling in human GBM) and high ZEB1 levels were linked to an aberrant cell cycle processing, marked by CDK1 overexpression.Keywords
This publication has 35 references indexed in Scilit:
- ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in GliomaPLOS ONE, 2012
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAsNature Cell Biology, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarityOncogene, 2007
- The epithelial–mesenchymal transition: new insights in signaling, development, and diseaseJournal of Cell Biology, 2006
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Differential expression of Wnt genes, β-catenin and E-cadherin in human brain tumorsCancer Letters, 2002